U.S. pharma large copyright scrapped two experimental weight loss pills previous yr—a at the time-every day pill, lotiglipron, resulting from elevated liver enzymes and also a 2 times-day-to-day capsule, danuglipron, due to solid Negative effects—but CEO Albert Bourla has reported th